Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/17 → 8/31/20 |
Funding
- Northwestern University
- Regeneron Pharmaceuticals, Inc.
Regeneron 1539: A PHASE 2/3 STUDY INVESTIGATING THE PHARMACOKINETICS, SAFETY, AND EFFICACY OF DUPILUMAB IN PATIENTS AGED ?6 MONTHS TO <6 YEARS WITH SEVERE ATOPIC DERMATITIS
- Paller, Amy (PD/PI)
Project: Research project